Psyence BioMed Announces Strategic Ibogaine Investment
Transactions include an investment of up to US$5 million in PsyLabs and an approximately US$9 million value-matched share exchange
Transactions include an investment of up to US$5 million in PsyLabs and an approximately US$9 million value-matched share exchange